Promino Nutritional Sciences Takes a Bold Step Forward
Promino Nutritional Sciences Inc. (CSE: MUSL, OTC: MUSLF) is on the verge of significant advancements as it launches a preclinical trial focused on demonstrating the effectiveness of its patented Promino™ intellectual property (IP) in helping cancer patients maintain muscle mass while undergoing intensive chemotherapy treatments. This trial will be conducted under the expert guidance of Dr. Patrick Gunning, who has recently come on board as an advisor to oversee this crucial research.
The Importance of the Preclinical Trial
The primary aim of this preclinical trial is to confirm how valuable Promino™ is in supporting muscle retention during aggressive cancer therapies. This is particularly vital because chemotherapy often results in substantial muscle loss, which can negatively affect patients’ strength and their recovery processes.
Dr. Patrick Gunning's Contribution
Dr. Gunning, with his extensive knowledge and experience, will play a crucial role in guiding the research team. His involvement raises hopes that the trial results will not only validate the use of Promino™ but also help in creating specialized formulas aimed at healthcare providers across North America.
Anticipation for Results
The trial results are anticipated within the next ten weeks. If this innovative patented formula shows positive outcomes, it could fundamentally change the way muscle loss is managed during chemotherapy. This trial holds the promise of paving the way for new therapeutic approaches that could greatly aid patients undergoing these tough treatments.
Insights from the CEO on the Patented Formula
Vito Sanzone, Promino's CEO, expressed his optimism regarding the trial, saying, "Our patented essential amino acid blend isn't just about quality protein; it could be a vital support for those in chemotherapy. We aim to provide solutions that help patients retain their strength during treatment.”
Promino's Achievements
Reflecting Promino’s dedication to innovation, the company has made notable progress and formed strategic partnerships. Recent milestones include collaborations with well-known retailers like Vitacost and iHerb, and the production of 65,000 units of its specialized supplements, Rejuvenate™ and Promino™.
Market Expansion and Reach
Promino is gearing up to strengthen its presence in the health and wellness industry, with a renewed focus on the direct-to-consumer market on the horizon. Additionally, partnerships with licensors will enable Promino to enhance its offerings in both ready-to-drink and powdered supplement categories.
Official Protein Drink for the Las Vegas Lights
Promino's increasing impact in the sports nutrition arena is highlighted by its designation as the "Official Protein Drink of the Las Vegas Lights" FC, a collaboration further amplified by brand ambassador Jose Bautista.
About Promino’s Offerings
Promino’s flagship product, Rejuvenate™, is a scientifically supported formulation aimed at rebuilding and restoring natural muscle mass. Meanwhile, Promino™ caters to both elite and everyday athletes, assisting them in improving recovery times and muscle strength.
Looking Ahead
As Promino Nutritional Sciences Inc. embarks on this promising preclinical trial, the focus remains on continually refining products that deliver therapeutic benefits. The company’s journey showcases the potential of nutraceutical innovations and a commitment to enhancing outcomes for individuals fighting cancer.
Frequently Asked Questions
What is the primary goal of Promino's preclinical trial?
The main aim is to demonstrate how effective Promino™ is in helping cancer patients maintain muscle mass during chemotherapy treatments.
Who leads the preclinical trial at Promino?
Dr. Patrick Gunning is taking the lead as a special advisor overseeing the preclinical trial at Promino.
When can we expect the trial results?
The results from the trial are expected to be available within ten weeks.
What major milestones has Promino recently reached?
Promino has formed key partnerships with major retailers and produced 65,000 units of its supplement offerings.
What is the primary product offered by Promino?
Rejuvenate™ is the flagship product from Promino, aimed at aiding in the restoration of natural muscle mass.
